Top Quality CAS 60-32-2 with 99% Purity 6-Aminocaproic Acid

• Function: Vitamins and Minerals Deficiency Drug
• Grade Standard: Medicine Grade
• Type: Chemical Reagent
• State: Powder
• Volatile: Not Volatile
• CAS: 60-32-2
• Model NO.: py0477
• Mf.: C6h13no2
• MOQ: 1kg
• Package: Carton
• Transport Package: 25kg/Drum
• Specification: 99%
• Trademark: puya
• Origin: China
• Production Capacity: 10ton/Year

Product Description

 CAS 60-32-2  6-Aminocaproic Acid
 

Product Name	6-Aminocaproic acid
CAS No.	60-32-2
Appearance	White crystalline powder
Assay	≥99%
Capacity	500mt/year
MOQ	1kg
Application	Organic Intermediate
Standard	Enterprise export
More Information	Synonyms: 6-Aminohexanoic acid Molecular Formula: C6H13NO2 Molecular Weight: 131.17 CAS Registry Number: 60-32-2 EINECS: 200-469-3  Melting point: 204-209 ºC

 

Melting point	207-209 °C (dec.) (lit.)
Boiling point	242.49°C (rough estimate)
density	1.042 g/cm3
vapor pressure	<0.1 hPa (20 °C)
refractive index	1.4870 (estimate)
Fp	207-209°C
storage temp.	Store below +30°C.
solubility	H2O: 50 mg/mL
pka	4.373(at 25ºC)
form	powder
color	white
Odor	Odorless

Specification

Items	Specification	Results
Appearance	White powder	White powder
Assay	99.0%min	99.26%
Ash	0.2%max	0.01%
Moisture	0.5%max	0.31%

Aminocaproic acid is a derivative and analogue of the amino acid lysine, which makes it an effective inhibitor for enzymes that bind that particular residue. Such enzymes include proteolytic enzymes like plasmin, the enzyme responsible for fibrinolysis. For this reason it is effective in treatment of certain bleeding disorders, and it is marketed as Amicar.
Aminocaproic acid is also an intermediate in the polymerization of Nylon-6, where it is formed by ring-opening hydrolysis of caprolactam.

Aminocaproic acid is used to treat excessive postoperative bleeding, especially after procedures in which a great amount of bleeding is expected, such as cardiac surgery. It can be given orally or intravenously. A meta-analysis found that lysine analogs like aminocaproic acid significantly reduced blood loss in patients undergoing coronary artery bypass grafting.
Aminocaproic acid can also be used to treat the overdose and/or toxic effects of the thrombolytic pharmacologic agents tissue plasminogen activator (commonly known as tPA) and streptokinase.